Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race†
Version of Record online: 26 JUL 2006
Copyright © 2006 American Association for the Study of Liver Diseases
Volume 44, Issue 2, pages 352–359, August 2006
How to Cite
He, X.-S., Ji, X., Hale, M. B., Cheung, R., Ahmed, A., Guo, Y., Nolan, G. P., Pfeffer, L. M., Wright, T. L., Risch, N., Tibshirani, R. and Greenberg, H. B. (2006), Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology, 44: 352–359. doi: 10.1002/hep.21267
Potential conflict of interest: Nothing to report.
- Issue online: 26 JUL 2006
- Version of Record online: 26 JUL 2006
- Manuscript Accepted: 10 MAY 2006
- Manuscript Received: 22 NOV 2005
- NIH. Grant Numbers: AI40034, DK56339, AI48216, AI66316
- Eli Lilly/Stanford University Program of Excellence in Hepatitis Research
- VA Medical Center Research Enhancement Award Program
Supplementary material for this article can be found on the H EPATOLOGY website ( http://interscience.wiley.com/jpages/0270-9139/suppmat/index.html ).
|jws-hep.21267.doc||575K||Table A. Average fold-change of ISGs in different patient groups|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.